Precision medicine of obesity as an integral part of type 2 diabetes management – past, present, and future - The Lancet Diabetes & Endocrinology

Frontiers Anti-obesity pharmacotherapy for treatment of pediatric type 2 diabetes: Review of the literature and lessons learned from adults

Frontiers Can type 1 diabetes be an unexpected complication of obesity?

Frontiers Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment Options

Frontiers Treatment of Acquired Hypothalamic Obesity: Now and the Future

CIMB, Free Full-Text

Frontiers Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments

The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits

Frontiers Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments

Type 2 diabetes - The Lancet

Medicina, Free Full-Text

Precision medicine

Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 - The Lancet

Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Nutrients, Free Full-Text

Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)